Fulcrum Therapeutics Inc. (FULC)
3.21
-0.03 (-0.93%)
At close: Mar 04, 2025, 11:53 AM
Fulcrum Therapeutics Revenue
Fulcrum Therapeutics reported an annual revenue of $2.81M, reflecting a -55.77% growth. For the quarter ending September 30, 2024, Fulcrum Therapeutics generated $0 in revenue.
Revenue (ttm)
$2.81M
Revenue Growth
-55.77%
Price / Sales Ratio
147.54
Revenue / Employee
$36.91K
Employees
76
Market Cap
173.27M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | % Change |
|---|---|---|
| Dec 31, 2023 | 2.81M | -55.77% |
| Dec 31, 2022 | 6.34M | -66.90% |
| Dec 31, 2021 | 19.16M | +117.19% |
| Dec 31, 2020 | 8.82M | n/a |